Giant cell aortitis of the ascending aorta without signs and symptoms of systemic vasculitis

Egl Ereminien, Rimantas Benetis, Remigijus Žaliūnas, Monika Biesevičienė

Full Text:

PDF

Abstract


We report a case of a patient with giant cell aortitis – a rare cause of aneurysm of the ascending aorta. Modern imaging techniques show promise in diagnosis, however the diagnosis only after hystopathotological examination was revealed
which changed the postoperative management - immunosuppression was started together with anticoagulation therapy. Aortic imaging was repeated to precisely assess the extent of the disease and also to monitor a long term clinical outcomes.
JRCD 2012; 1: 10–12


Key words: Aortic aneurysm; Imaging; Surgery


References


Borg FA, Dasgupta B. Treatment and outcomes of large vessel arteritis. Best practice & Research Clinical Rheumatology 2009; 23: 325–337.

Mukhtyar C, Guilevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68: 318–323.

Boodhwani M, Kerchove L, Glineur D, et al. Repair-oriented classification of aortic insufficiency: Impact on surgical techniques and clinical outcomes. J Thorac Cardiovasc Surg 2009; 137: 286–294.

Nuenninghoff DM, Hunder GG, Christianson THJ, et al. Incidence and predictors of large artery complication (aortic aneurysm, aortic dissection and/or large artery stenosis) in patients with giant cell arteritis. Arthritis Rheum 2003; 48: 3522–3531.

Smetana GW, Shmerling RH. Does this patient has temporal arteritis. JAMA 2002; 287: 92–101.

Bley TA, Uhl M, Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007; 28: 1722–1727.

Walter M, Meizer RA, Schindler C, et al. The value of FDG-PET in the diagnosis of laerge vessel vasculitis and the assessment of the activity and extent of disease. Eur J Nucl Med Mol Imaging 2005; 32: 674–681.

Proven A, Gabriel SE, Orces C, et al. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Reum 2003; 49: 703–708.

Lee MS, Smith SD, Galor A, et al. Antiplatelet and anticoagulant therapy in patientswith giant cell arteritis. Arthritis Rheum 2006; 54: 3306–3309.

Wang HE, Smith RN, Spooner AE, et al. Giant cell aortitis of the ascending aorta without signs or symptoms of systemic vasculitis is associated with elevated risk of distal aortic events. Arthritis & Rheumatism 2012; 64: 317




DOI: http://dx.doi.org/10.20418%2Fjrcd.vol1no1.23

Refbacks

  • There are currently no refbacks.
Journal of Rare Cardiovascular Diseases (JRCD)
John Paul II Hospital in Kraków, 80 Prądnicka Str., 31-202 Kraków, Poland
Phone: +48 (12) 614 33 99, +48 (12) 614 34 88 Fax: +48 (12) 614 34 88
e-mail: rarediseases@szpitaljp2.krakow.pl
Published by SoftQ sp. z o.o.
ul. Oleandry 2, 30-063 Kraków, Poland
Phone: +48 (12) 444 1650 Fax: +48 (12) 444 1659
e-mail: softq@softq.pl